Sirtuins: critical regulators at the crossroads between cancer and aging (original) (raw)
Abdelmohsen K, Pullmann Jr R, Lal A, Kim HH, Galban S, Yang X et al. (2007). Phosphorylation of HuR by Chk2 Regulates SIRT1 Expression. Mol Cell25: 543–557. ArticleCASPubMedPubMed Central Google Scholar
Aksoy P, Escande C, White TA, Thompson M, Soares S, Benech JC et al. (2006a). Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. Biochem Biophys Res Commun349: 353–359. CASPubMed Google Scholar
Aksoy P, White TA, Thompson M, Chini EN . (2006b). Regulation of intracellular levels of NAD: a novel role for CD38. Biochem Biophys Res Commun345: 1386–1392. CASPubMed Google Scholar
Ando K, Higami Y, Tsuchiya T, Kanematsu T, Shimokawa I . (2002). Impact of aging and life-long calorie restriction on expression of apoptosis-related genes in male F344 rat liver. Microsc Res Tech59: 293–300. CASPubMed Google Scholar
Anisimov VN, Zhukovskaya NV, Loktionov AS, Vasilyeva IA, Kaminskaya EV, Vakhtin YB . (1988). Influence of host age on lung colony forming capacity of injected rat rhabdomyosarcoma cells. Cancer Lett40: 77–82. CASPubMed Google Scholar
Ashburner BP, Westerheide SD, Baldwin Jr AS . (2001). The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol21: 7065–7077. CASPubMedPubMed Central Google Scholar
Ashraf N, Zino S, Macintyre A, Kingsmore D, Payne AP, George WD et al. (2006). Altered sirtuin expression is associated with node-positive breast cancer. Br J Cancer95: 1056–1061. CASPubMedPubMed Central Google Scholar
Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR et al. (2007). Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol (in press).
Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD et al. (2001). Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell8: 1243–1254. CASPubMed Google Scholar
Bereshchenko OR, Gu W, Dalla-Favera R . (2002). Acetylation inactivates the transcriptional repressor BCL6. Nat Genet32: 606–613. CASPubMed Google Scholar
Berrigan D, Perkins SN, Haines DC, Hursting SD . (2002). Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis23: 817–822. CASPubMed Google Scholar
Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA . (2002). Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem277: 45099–45107. CASPubMed Google Scholar
Bluher M, Kahn BB, Kahn CR . (2003). Extended longevity in mice lacking the insulin receptor in adipose tissue. Science299: 572–574. PubMed Google Scholar
Bradbury CA, Khanim FL, Hayden R, Bunce CM, White DA, Drayson MT et al. (2005). Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia19: 1751–1759. CASPubMed Google Scholar
Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y et al. (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science303: 2011–2015. CASPubMed Google Scholar
Campisi J . (2005). Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell120: 513–522. CASPubMed Google Scholar
Chen LF, Mu Y, Greene WC . (2002). Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J21: 6539–6548. CASPubMedPubMed Central Google Scholar
Chen W, Cooper TK, Zahnow CA, Overholtzer M, Zhao Z, Ladanyi M et al. (2004). Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell6: 387–398. CASPubMed Google Scholar
Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB . (2005). Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell123: 437–448. CASPubMed Google Scholar
Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M et al. (2003). Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet33: 197–202. CASPubMed Google Scholar
Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P et al. (2003). Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA100: 10794–10799. CASPubMedPubMed Central Google Scholar
Chu F, Chou PM, Zheng X, Mirkin BL, Rebbaa A . (2005). Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1. Cancer Res65: 10183–10187. CASPubMed Google Scholar
Chua KF, Mostoslavsky R, Lombard DB, Pang WW, Saito S, Franco S et al. (2005). Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab2: 67–76. CASPubMed Google Scholar
Cohen HY, Lavu S, Bitterman KJ, Hekking B, Imahiyerobo TA, Miller C et al. (2004a). Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell13: 627–638. CASPubMed Google Scholar
Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B et al. (2004b). Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science305: 390–392. CASPubMed Google Scholar
Dai JM, Wang ZY, Sun DC, Lin RX, Wang SQ . (2007). SIRT1 interacts with p73 and suppresses p73-dependent transcriptional activity. J Cell Physiol210: 161–166. CASPubMed Google Scholar
Daitoku H, Hatta M, Matsuzaki H, Aratani S, Ohshima T, Miyagishi M et al. (2004). Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci USA101: 10042–10047. CASPubMedPubMed Central Google Scholar
Dawid IB, Breen JJ, Toyama R . (1998). LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends Genet14: 156–162. CASPubMed Google Scholar
De Nigris F, Cerutti J, Morelli C, Califano D, Chiariotti L, Viglietto G et al. (2002). Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues. Br J Cancer87: 1479. CASPubMedPubMed Central Google Scholar
DeGregori J, Johnson DG . (2006). Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med6: 739–748. CASPubMed Google Scholar
Dhordain P, Lin RJ, Quief S, Lantoine D, Kerckaert JP, Evans RM et al. (1998). The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res26: 4645–4651. CASPubMedPubMed Central Google Scholar
Dryden SC, Nahhas FA, Nowak JE, Goustin AS, Tainsky MA . (2003). Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol23: 3173–3185. CASPubMedPubMed Central Google Scholar
Feng L, Lin T, Uranishi H, Gu W, Xu Y . (2005). Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol Cell Biol25: 5389–5395. CASPubMedPubMed Central Google Scholar
Finkel T, Holbrook NJ . (2000). Oxidants, oxidative stress and the biology of ageing. Nature408: 239–247. CASPubMed Google Scholar
Ford E, Voit R, Liszt G, Magin C, Grummt I, Guarente L . (2006). Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev20: 1075–1080. CASPubMedPubMed Central Google Scholar
Ford J, Jiang M, Milner J . (2005). Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res65: 10457–10463. CASPubMed Google Scholar
Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G et al. (2005). Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet37: 391–400. CASPubMed Google Scholar
Frye RA . (1999). Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun260: 273–279. CASPubMed Google Scholar
Fu M, Liu M, Sauve AA, Jiao X, Zhang X, Wu X et al. (2006). Hormonal control of androgen receptor function through SIRT1. Mol Cell Biol26: 8122–8135. CASPubMedPubMed Central Google Scholar
Fu M, Rao M, Wang C, Sakamaki T, Wang J, Di Vizio D et al. (2003). Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol23: 8563–8575. CASPubMedPubMed Central Google Scholar
Fu M, Wang C, Reutens AT, Wang J, Angeletti RH, Siconolfi-Baez L et al. (2000). p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem275: 20853–20860. CASPubMed Google Scholar
Fukuoka M, Daitoku H, Hatta M, Matsuzaki H, Umemura S, Fukamizu A . (2003). Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation. Int J Mol Med12: 503–508. CASPubMed Google Scholar
Fulco M, Schiltz RL, Iezzi S, King MT, Zhao P, Kashiwaya Y et al. (2003). Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell12: 51–62. CASPubMed Google Scholar
Fulda S, Debatin KM . (2006). Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review. Cancer Detect Prev30: 217–223. CASPubMed Google Scholar
Funayama R, Saito M, Tanobe H, Ishikawa F . (2006). Loss of linker histone H1 in cellular senescence. J Cell Biol175: 869–880. CASPubMedPubMed Central Google Scholar
Furukawa-Hibi Y, Kobayashi Y, Chen C, Motoyama N . (2005). FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. Antioxid Redox Signal7: 752–760. CASPubMed Google Scholar
Gil J, Bernard D, Peters G . (2005). Role of polycomb group proteins in stem cell self-renewal and cancer. DNA Cell Biol24: 117–125. CASPubMed Google Scholar
Glatt SJ, Chayavichitsilp P, Depp C, Schork NJ, Jeste DV . (2007). Successful aging: from phenotype to genotype. Biol Psychiatry (in press). CASPubMed Google Scholar
Haigis MC, Mostoslavsky R, Haigis KM, Fahie K, Christodoulou DC, Murphy AJ et al. (2006). SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell126: 941–954. CASPubMed Google Scholar
Hallows WC, Lee S, Denu JM . (2006). Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci USA103: 10230–10235. CASPubMedPubMed Central Google Scholar
Han X, Berardi P, Riabowol K . (2006). Chromatin modification and senescence: linkage by tumor suppressors? Rejuvenation Res9: 69–76. CASPubMed Google Scholar
Hanahan D, Weinberg RA . (2000). The hallmarks of cancer. Cell100: 57–70. CASPubMed Google Scholar
Hassa PO, Haenni SS, Elser M, Hottiger MO . (2006). Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev70: 789–829. CASPubMedPubMed Central Google Scholar
Heltweg B, Gatbonton T, Schuler AD, Posakony J, Li H, Goehle S et al. (2006). Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res66: 4368–4377. CASPubMed Google Scholar
Hida Y, Kubo Y, Murao K, Arase S . (2006). Strong expression of a longevity-related protein, SIRT1, in Bowen's disease. Arch Dermatol Res239: 103–106. Google Scholar
Higami Y, Shimokawa I, Tomita M, Okimoto T, Koji T, Kobayashi N et al. (1997). Aging accelerates but life-long dietary restriction suppresses apoptosis-related Fas expression on hepatocytes. Am J Pathol151: 659–663. CASPubMedPubMed Central Google Scholar
Hiratsuka M, Inoue T, Toda T, Kimura N, Shirayoshi Y, Kamitani H et al. (2003). Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene. Biochem Biophys Res Commun309: 558–566. CASPubMed Google Scholar
Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T et al. (1994). Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res22: 3551–3555. CASPubMedPubMed Central Google Scholar
Holmes-McNary M, Baldwin Jr AS . (2000). Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res60: 3477–3483. CASPubMed Google Scholar
Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A et al. (2002). HDAC6 is a microtubule-associated deacetylase. Nature417: 455–458. CASPubMed Google Scholar
Huffman DM, Johnson MS, Watts A, Elgavish A, Eltoum IA, Nagy TR . (2007). Cancer progression in the transgenic adenocarcinoma of mouse prostate mouse is related to energy balance, body mass, and body composition, but not food intake. Cancer Res67: 417–424. CASPubMed Google Scholar
Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC . (2003). Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med54: 131–152. CASPubMed Google Scholar
Imai S, Armstrong CM, Kaeberlein M, Guarente L . (2000). Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature403: 795–800. CASPubMed Google Scholar
Inoue T, Hiratsuka M, Osaki M, Yamada H, Kishimoto I, Yamaguchi S et al. (2006). SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress. Oncogene26: 945–947. PubMed Google Scholar
Itahana K, Dimri G, Campisi J . (2001). Regulation of cellular senescence by p53. Eur J Biochem268: 2784–2791. CASPubMed Google Scholar
Iyer NG, Ozdag H, Caldas C . (2004). p300/CBP and cancer. Oncogene23: 4225–4231. CASPubMed Google Scholar
Jackson MD, Schmidt MT, Oppenheimer NJ, Denu JM . (2003). Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases. J Biol Chem278: 50985–50998. CASPubMed Google Scholar
Jeppesen P, Turner BM . (1993). The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression. Cell74: 281–289. CASPubMed Google Scholar
Jones JM, Attardi L, Godley LA, Laucirica R, Medina D, Jacks T et al. (1997). Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis. Cell Growth Differ8: 829–838. CASPubMed Google Scholar
Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R et al. (2006). Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res66: 11341–11347. CASPubMed Google Scholar
Kalkhoven E, Teunissen H, Houweling A, Verrijzer CP, Zantema A . (2002). The PHD type zinc finger is an integral part of the CBP acetyltransferase domain. Mol Cell Biol22: 1961–1970. CASPubMedPubMed Central Google Scholar
Kamel C, Abrol M, Jardine K, He X, McBurney MW . (2006). SirT1 fails to affect p53-mediated biological functions. Aging Cell5: 81–88. CASPubMed Google Scholar
Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, Sardet C et al. (2003). Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem278: 2758–2766. CASPubMed Google Scholar
Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J et al. (2006). Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell23: 607–618. CASPubMed Google Scholar
Kobayashi Y, Furukawa-Hibi Y, Chen C, Horio Y, Isobe K, Ikeda K et al. (2005). SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. Int J Mol Med16: 237–243. CASPubMed Google Scholar
Krummel KA, Lee CJ, Toledo F, Wahl GM . (2005). The C terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. Proc Natl Acad Sci USA102: 10188–10193. CASPubMedPubMed Central Google Scholar
Kuzmichev A, Margueron R, Vaquero A, Preissner TS, Scher M, Kirmizis A et al. (2005). Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci USA102: 1859–1864. CASPubMedPubMed Central Google Scholar
Labalette C, Renard CA, Neuveut C, Buendia MA, Wei Y . (2004). Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin. Mol Cell Biol24: 10689–10702. CASPubMedPubMed Central Google Scholar
Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L et al. (2000). The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci USA97: 5807–5811. CASPubMedPubMed Central Google Scholar
Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S et al. (2002). Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J21: 2383–2396. CASPubMedPubMed Central Google Scholar
Lennox RW, Cohen LH . (1983). The histone H1 complements of dividing and nondividing cells of the mouse. J Biol Chem258: 262–268. CASPubMed Google Scholar
Li F, Chong ZZ, Maiese K . (2006). Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide. Curr Med Chem13: 883–895. CASPubMedPubMed Central Google Scholar
Lim CS, Potts M, Helm RF . (2006). Nicotinamide extends the replicative life span of primary human cells. Mech Ageing Dev127: 511–514. CASPubMed Google Scholar
Liszt G, Ford E, Kurtev M, Guarente L . (2005). Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem280: 21313–21320. CASPubMed Google Scholar
Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR et al. (2006). Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer5: 67. PubMedPubMed Central Google Scholar
Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt FW . (2005). DNA repair, genome stability, and aging. Cell120: 497–512. CASPubMed Google Scholar
Longo VD, Kennedy BK . (2006). Sirtuins in aging and age-related disease. Cell126: 257–268. CASPubMed Google Scholar
Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A et al. (2001). Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell107: 137–148. CASPubMed Google Scholar
Mai V, Colbert LH, Berrigan D, Perkins SN, Pfeiffer R, Lavigne JA et al. (2003). Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. Cancer Res63: 1752–1755. CASPubMed Google Scholar
Manna SK, Mukhopadhyay A, Aggarwal BB . (2000). Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol164: 6509–6519. CASPubMed Google Scholar
Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T . (2000). Regulation of E2F1 activity by acetylation. EMBO J19: 662–671. CASPubMedPubMed Central Google Scholar
Matsuyama A, Shimazu T, Sumida Y, Saito A, Yoshimatsu Y, Seigneurin-Berny D et al. (2002). In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J21: 6820–6831. CASPubMedPubMed Central Google Scholar
McLure KG, Takagi M, Kastan MB . (2004). NAD+ modulates p53 DNA binding specificity and function. Mol Cell Biol24: 9958–9967. CASPubMedPubMed Central Google Scholar
Mendoza-Alvarez H, Alvarez-Gonzalez R . (2001). Regulation of p53 sequence-specific DNA-binding by covalent poly(ADP-ribosyl)ation. J Biol Chem276: 36425–36430. CASPubMed Google Scholar
Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I . (2005). Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell16: 4623–4635. CASPubMedPubMed Central Google Scholar
Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L et al. (2006). Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell124: 315–329. CASPubMed Google Scholar
Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W et al. (2004). Mammalian SIRT1 represses forkhead transcription factors. Cell116: 551–563. CASPubMed Google Scholar
Muller JM, Metzger E, Greschik H, Bosserhoff AK, Mercep L, Buettner R et al. (2002). The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J21: 736–748. CASPubMedPubMed Central Google Scholar
Narita M, Nunez S, Heard E, Lin AW, Hearn SA, Spector DL et al. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell113: 703–716. CASPubMed Google Scholar
Nemoto S, Fergusson MM, Finkel T . (2004). Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science306: 2105–2108. CASPubMed Google Scholar
Niu H . (2002). The protooncogene BCL-6 in normal and malignant B cell development. Hematol Oncol20: 155–166. PubMed Google Scholar
Niu H, Ye BH, Dalla-Favera R . (1998). Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev12: 1953–1961. CASPubMedPubMed Central Google Scholar
North BJ, Marshall BL, Borra MT, Denu JM, Verdin E . (2003). The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell11: 437–444. CASPubMed Google Scholar
North BJ, Verdin E . (2004). Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol5: 224. PubMedPubMed Central Google Scholar
Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP . (2002). SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci USA99: 13653–13658. CASPubMedPubMed Central Google Scholar
Ota H, Tokunaga E, Chang K, Hikasa M, Iijima K, Eto M et al. (2006). Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene25: 176–185. CASPubMed Google Scholar
Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S et al. (2000). PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature406: 207–210. CASPubMed Google Scholar
Piperno G, LeDizet M, Chang XJ . (1987). Microtubules containing acetylated alpha-tubulin in mammalian cells in culture. J Cell Biol104: 289–302. CASPubMed Google Scholar
Piva R, Belardo G, Santoro MG . (2006). NF-kappaB: a stress-regulated switch for cell survival. Antioxid Redox Signal8: 478–486. CASPubMed Google Scholar
Poirier GG, Savard P . (1980). ADP-ribosylation of pancreatic histone H1 and of other histones. Can J Biochem58: 509–515. CASPubMed Google Scholar
Porcu M, Chiarugi A . (2005). The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension. Trends Pharmacol Sci26: 94–103. CASPubMed Google Scholar
Revollo JR, Grimm AA, Imai S . (2004). The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem279: 50754–50763. CASPubMed Google Scholar
Reya T, Morrison SJ, Clarke MF, Weissman IL . (2001). Stem cells, cancer, and cancer stem cells. Nature414: 105–111. CASPubMed Google Scholar
Rose G, Dato S, Altomare K, Bellizzi D, Garasto S, Greco V et al. (2003). Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp Gerontol38: 1065–1070. CASPubMed Google Scholar
Roth GS, Ingram DK, Lane MA . (2001). Caloric restriction in primates and relevance to humans. Ann N Y Acad Sci928: 305–315. CASPubMed Google Scholar
Rowinsky EK, Calvo E . (2006). Novel agents that target tubulin and related elements. Semin Oncol33: 421–435. CASPubMed Google Scholar
Sawada M, Sun W, Hayes P, Leskov K, Boothman DA, Matsuyama S . (2003). Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol5: 320–329. CASPubMed Google Scholar
Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G . (2007). Genome regulation by polycomb and trithorax proteins. Cell128: 735–745. CASPubMed Google Scholar
Schwer B, Bunkenborg J, Verdin RO, Andersen JS, Verdin E . (2006). Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci USA103: 10224–10229. CASPubMedPubMed Central Google Scholar
Schwer B, North BJ, Frye RA, Ott M, Verdin E . (2002). The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol158: 647–657. CASPubMedPubMed Central Google Scholar
Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M et al. (2005). Global histone modification patterns predict risk of prostate cancer recurrence. Nature435: 1262–1266. CASPubMed Google Scholar
Shand RL, Gelmann EP . (2006). Molecular biology of prostate-cancer pathogenesis. Curr Opin Urol16: 123–131. PubMed Google Scholar
Shi T, Wang F, Stieren E, Tong Q . (2005). SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem280: 13560–13567. CASPubMed Google Scholar
Simbulan-Rosenthal CM, Rosenthal DS, Luo RB, Samara R, Jung M, Dritschilo A et al. (2001). Poly(ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence. Neoplasia3: 179–188. CASPubMedPubMed Central Google Scholar
Singh P, Uzgare A, Litvinov I, Denmeade SR, Isaacs JT . (2006). Combinatorial androgen receptor targeted therapy for prostate cancer. Endocr Relat Cancer13: 653–666. CASPubMed Google Scholar
Smith JS, Brachmann CB, Celic I, Kenna MA, Muhammad S, Starai VJ et al. (2000). A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc Natl Acad Sci USA97: 6658–6663. CASPubMedPubMed Central Google Scholar
Solomon JM, Pasupuleti R, Xu L, McDonagh T, Curtis R, DiStefano PS et al. (2006). Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol26: 28–38. CASPubMedPubMed Central Google Scholar
Sommer M, Poliak N, Upadhyay S, Ratovitski E, Nelkin BD, Donehower LA et al. (2006). DeltaNp63alpha overexpression induces downregulation of Sirt1 and an accelerated aging phenotype in the mouse. Cell Cycle5: 2005–2011. CASPubMed Google Scholar
Stankovic-Valentin N, Deltour S, Seeler J, Pinte S, Vergoten G, Guerardel C et al. (2007). An Acetylation/Deacetylation-SUMOylation switch through a phylogenetically conserved {psi}KxEP motif in the tumor suppressor HIC1 (Hypermethylated in Cancer 1) regulates transcriptional repression activity. Mol Cell Biol27: 2661–2675. CASPubMedPubMed Central Google Scholar
Strickler HD, Wylie-Rosett J, Rohan T, Hoover DR, Smoller S, Burk RD et al. (2001). The relation of type 2 diabetes and cancer. Diabetes Technol Ther3: 263–274. CASPubMed Google Scholar
Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y . (2006). Nucleo-cytoplasmic shuttling of NAD+-dependent histone deacetylase SIRT1. J Biol Chem282: 6823–6832. PubMed Google Scholar
Thompson PR, Wang D, Wang L, Fulco M, Pediconi N, Zhang D et al. (2004). Regulation of the p300 HAT domain via a novel activation loop. Nat Struct Mol Biol11: 308–315. CASPubMed Google Scholar
Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H et al. (2002). p53 mutant mice that display early ageing-associated phenotypes. Nature415: 45–53. CASPubMed Google Scholar
Vainio H, Kaaks R, Bianchini F . (2002). Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev11 (Suppl 2): S94–S100. PubMed Google Scholar
van der Heide LP, Smidt MP . (2005). Regulation of FoxO activity by CBP/p300-mediated acetylation. Trends Biochem Sci30: 81–86. CASPubMed Google Scholar
van der Horst A, Tertoolen LG, de Vries-Smits LM, Frye RA, Medema RH, Burgering BM . (2004). FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J Biol Chem279: 28873–28879. CASPubMed Google Scholar
van der Veer E, Ho C, O'Neil C, Barbosa N, Scott R, Cregan SP et al. (2007). Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J Biol Chem282: 10841–10845. CASPubMed Google Scholar
Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, Reinberg D . (2004). Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell16: 93–105. CASPubMed Google Scholar
Vaquero A, Scher MB, Lee DH, Sutton A, Cheng HL, Alt FW et al. (2006). SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev20: 1256–1261. CASPubMedPubMed Central Google Scholar
Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK et al. (2001). hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell107: 149–159. CASPubMed Google Scholar
Vousden KH, Lu X . (2002). Live or let die: the cell's response to p53. Nat Rev Cancer2: 594–604. CASPubMed Google Scholar
Wang C, Chen L, Hou X, Li Z, Kabra N, Ma Y et al. (2006). Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol8: 1025–1031. CASPubMed Google Scholar
Wang W, Yang X, Cristofalo VJ, Holbrook NJ, Gorospe M . (2001). Loss of HuR is linked to reduced expression of proliferative genes during replicative senescence. Mol Cell Biol21: 5889–5898. CASPubMedPubMed Central Google Scholar
Waterbor JW, Bueschen AJ . (1995). Prostate cancer screening (United States). Cancer Causes Control6: 267–274. CASPubMed Google Scholar
Yamamoto H, Okamoto H . (1980). Protection by picolinamide, a novel inhibitor of poly (ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets. Biochem Biophys Res Commun95: 474–481. CASPubMed Google Scholar
Yang T, Sauve A . (2006). NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity. Aaps J8: E632–E643. PubMedPubMed Central Google Scholar
Yang Y, Hou H, Haller EM, Nicosia SV, Bai W . (2005). Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J24: 1021–1032. CASPubMedPubMed Central Google Scholar
Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA et al. (2004). Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J23: 2369–2380. CASPubMedPubMed Central Google Scholar
Zhang J . (2003). Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked? Bioessays25: 808–814. CASPubMed Google Scholar
Zhong H, May MJ, Jimi E, Ghosh S . (2002). The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell9: 625–636. CASPubMed Google Scholar